• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY MITEK LLC US OMNISPAN MENISCAL REPAIR, 0DEG; SOFT-TISSUE ANCHOR, BIOABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY MITEK LLC US OMNISPAN MENISCAL REPAIR, 0DEG; SOFT-TISSUE ANCHOR, BIOABSORBABLE Back to Search Results
Catalog Number 228140
Medical Device Problem Code Component Missing (2306)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 06/06/2019
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Product complaint # (b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.Udi: (b)(4).
 
Event or Problem Description
It was reported by the affiliate via email that prior to a procedure the omnispan meniscal repair 0 degree was brand new and the physician could not find the second needle part.Another product of the same type was used to complete the procedure.No consequences for the patient reported.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.The complaint device was received and evaluated.Upon visual evaluation, it can be noticed that the first implant appears to be fired whereas the second implant remains in place.The silicon sleeve remains in place with a bulged bump from the fired implant.There is no evidence of a missing part; therefore, we cannot confirm the complaint.Given the information provided by the customer, it is unclear how the first implant was released.A definite root cause could not be established.No nonconformances were identified for this part number, lot number combination per qlik query executed on 6/10/2019.At this point in time, no corrective action is required and no further action is warranted.However, depuy synthes mitek will continue to track any related complaints within this device family as a means of monitoring the extent with which this complaint is observed in the field.Udi: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNISPAN MENISCAL REPAIR, 0DEG
Common Device Name
SOFT-TISSUE ANCHOR, BIOABSORBABLE
Manufacturer (Section D)
DEPUY MITEK LLC US
325 paramount drive
raynham MA 02767
MDR Report Key8761410
Report Number1221934-2019-57544
Device Sequence Number1488853
Product Code MAI
UDI-Device Identifier10886705010028
UDI-Public10886705010028
Combination Product (Y/N)N
Initial Reporter CountryPL
PMA/510(K) Number
K150209
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,other
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 06/10/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/31/2021
Device Catalogue Number228140
Device Lot Number1L49179
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/08/2019
Initial Date Received by Manufacturer 06/10/2019
Supplement Date Received by Manufacturer08/08/2019
Initial Report FDA Received Date07/03/2019
Supplement Report FDA Received Date08/30/2019
Patient Sequence Number1
-
-